Quantum Capital Management (California)’s Novo Nordisk NVO Stock Holding History

Quantum Capital Management (California)’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$89K	Sell	2,588 -290	-10%	-$9.67K	0.1%	119
2020 Q2	$94K	Sell	2,878 -666	-19%	-$21.3K	0.05%	173
2020 Q1	$107K	Sell	3,544 -722	-17%	-$21.5K	0.07%	167
2019 Q4	$123K	Sell	4,266 -62	-1%	-$1.72K	0.06%	184
2019 Q3	$112K	Buy	+4,328	New	+$109K	0.06%	204
2015 Q3	–	Sell	-7,964	Closed	-$218K	–	170
2015 Q2	$218K	Buy	7,964 +318	+4%	+$8.94K	0.03%	145
2015 Q1	$204K	Buy	+7,646	New	+$176K	0.04%	164

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

Quantum Capital Management (California)'s NVO Position: Q3 2020 in Review

Quantum Capital Management (California) reduced its Novo Nordisk (NVO) stake by 10% in Q3 2020, selling an estimated $9.67K and leaving 2,588 shares worth $89K. The position accounts for 0.1% of the portfolio, ranked #119.

Quantum Capital Management (California) first reported a position in NVO in Q1 2015 and has held it in 7 quarters since. The position peaked at $218K in Q2 2015. 660 funds tracked by Wall St. Rank hold NVO as of Q3 2020.

Quantum Capital Management (California) held 2,588 shares of Novo Nordisk worth $89K as of Q3 2020.
Quantum Capital Management (California) sold 290 Novo Nordisk shares in Q3 2020, an estimated $9.67K.
Novo Nordisk made up 0.1% of Quantum Capital Management (California)'s portfolio in Q3 2020, its #119 holding.
Quantum Capital Management (California) first reported a position in Novo Nordisk in Q1 2015 and has held it in 7 quarters since.
Quantum Capital Management (California)'s Novo Nordisk position peaked at $218K in Q2 2015.
660 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2020.

Based on Quantum Capital Management (California)'s 13F filing for Q3 2020, filed 16 Nov 2020.